Angelov Angel S reported VTGN

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002132062-26-000004

Machine-readable

Structured copy

Timestamps

Event (reported)

May 18, 2026

Published

May 19, 2026

Ingested by INSIDER

Nov 5, 03:57 UTC

Last re-read

Nov 5, 03:57 UTC

Extracted facts

Filer

Angelov Angel S

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

Vistagen Therapeutics, Inc. — Stock Option (Right to Buy)

Ticker

VTGN

Shares

150.0K

Execution date (reported)

May 18, 2026

Owned after transaction

150.0K shares

Days from execution to publication

1

What this establishes

Angelov Angel S filed this Form 4 reporting a grant or award of VTGN on May 18, 2026. It became public on May 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Angelov Angel Scik:0002132062

Issuer

Vistagen Therapeutics, Inc.cik:0001411685

Revision history · 0

No field has changed since this record was first ingested.